Title
Clomifene Citrate as First Line Treatment in in Vitro Fertilization Cycles for Patients With Lower Ovarian Reserve
Patients With Reduced Ovarian Reserve and In Vitro Fertilization (IVF) Cycles. A Randomized Multicentric Comparison of a Protocol With High Doses of Gonadotropins and a Protocol With Clomiphene Citrate Only. Evaluation of Clinical Effectiveness and Economic Issues
Phase
N/ALead Sponsor
University of MilanStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
InfertilityIntervention/Treatment
follitropin alfa triptorelin clomifene ...Study Participants
289Women with compromised ovarian reserve requiring in vitro fertilization (IVF) still represent a demanding challenge for clinicians. It has classically been claimed that using higher dosages of gonadotropins may overcome the scarce ovarian responsiveness to hyper-simulation and increase the chances of success. However, scientific evidence supporting this view is scanty and costs are inevitably much higher. In this study, the investigators hypothesized that similar chances of pregnancy may be achieved with a mild stimulation using exclusively Clomiphene citrate (CC).
3x50 mg die for 5 days from day 3 to day 7 of the menstrual cycle
daily subcutaneous 0.1 mg decapeptyl from day 1-2 of the menstrual cycle and recombinant human FSH 450 IU/die from day 3.
Administration of high doses of gonadotrophins to stimulate ovarian follicular growth
Administration of Clomiphene Citrate to obtain ovarian follicular growth
Inclusion Criteria: age 18-42 years infertility status Day 3 serum FSH > 12 IU/ml in at least two occasions or previous poor response (≤3 oocytes retrieved) to hyper-stimulation Exclusion Criteria: contraindications to infertility treatments or pregnancy